Hirai Daisuke, Yamashita Yugo, Masunaga Nobutoyo, Katsura Toshiaki, Akao Masaharu, Okuno Yoshiaki, Koyama Hiroshi
Departmant of General Medicine, National Hospital Organization Kyoto Medical Center, Japan.
Intern Med. 2016;55(20):3039-3042. doi: 10.2169/internalmedicine.55.6459. Epub 2016 Oct 15.
Inhibitors directed against factor V rarely occur, and the clinical symptoms vary. We herein report the case of a patient who presented with a decreased factor V activity that had decreased to <3 %. We administered vitamin K and 6 units of fresh frozen plasma, but she thereafter developed an intracerebral hemorrhage. It is unclear whether surgery >10 years earlier might have caused the development of a factor V inhibitor. The treatment of acquired factor V inhibitors is mainly the transfusion of platelet concentrates and corticosteroids. Both early detection and the early initiation of the treatment of factor V inhibitor are thus considered to be important.
针对凝血因子V的抑制剂很少见,且临床症状各异。我们在此报告一例患者,其凝血因子V活性降低至<3%。我们给予了维生素K和6单位新鲜冰冻血浆,但此后她发生了脑出血。目前尚不清楚10多年前的手术是否可能导致了凝血因子V抑制剂的产生。获得性凝血因子V抑制剂的治疗主要是输注血小板浓缩物和使用皮质类固醇。因此,早期发现和尽早开始治疗凝血因子V抑制剂都被认为很重要。